Persistent virus infections either show steady and relentless progress-scrapie, visna, or maedi-or persistence with reactivation, as does varicella-zoster. In either case host defence mechanisms are unable to control the infection. To understand the underlying defects it is necessary to know what limits the progress of virus infections under normal conditions. Several factors contribute to host resistance against viruses, and it is becoming apparent that their relative importance varies from one virus infection to another. The main findings will be reviewed in this paper, together with available observations on immune responses to persistent viruses. The simplest way to achieve progressive infections is for the agent responsible to be non-immunogenic, and this, as far as we know, is true of scrapie and related agents. Speculations on why immune responses are ineffective in other persistent virus infections can be offered. Immunopathological reactions to virus infections are also attracting current interest. Since they contribute to the lesions observed in persistent virus infections, they are also briefly considered in this paper.
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Mechanisms of Resistance against Viruses
The term 'immunity' can be used in a broad sense to describe any form of resistance against a potentially pathogenic organism or toxin. Immunity against viruses has many components, including resistance of individual host cells to infection, local factors such as temperature or acidity, formation of interferon, resistance of macrophages and other leucocytes, and specific humoral and cell-mediated immune responses. The situation is obviously complex, but my colleagues and I have been attempting to find out whether it is possible to show that in particular virushost combinations some resistance factors are more important than others.
We have used several techniques to eliminate one or more resistance factors. Unfortunately, none of the available immunosuppressive techniques is sufficiently selective to give unambiguous information by itself. Even neonatal thymectomy and administration of antilymphocytic serum (ALS), pro- cedures that powerfully suppress cell-mediated immunity, also decrease antibody production, especially where cooperation of thymus-dependent (T) with antibody-producing (B) cells is required for an efficient response, which is the case with some viral antigens. It is therefore necessary to examine the effects of selective restoration of immune responses in immunosuppressed animals. Passive protection by serum antibody provides highly suggestive evidence that antibody can provide the critical factor controlling an infection. If antibody alone provides no protection but transfer of specifically sensitized lymphoid cells does protect, this is strong evidence that cell-mediated immunity plays a major defensive role-although extravascular production of IgM or of cytophilic antibody in recipients could be involved.
The results of animal experiments complement remarkably well observations which have been made on human patients with immunodeficiency syndromes. Although there are many gaps in knowledge, a general picture is emerging. The first major line of defence is the inherent resistance of cells at the primary site of infection; this enables cells to overcome exposure to most viruses from other species and, where there are individual inherited differences, to certain homologous viruses also. With infections of seromucous surfaces such as the respiratory or alimentary tracts, the major second line of defence is secretory antibody, which is synthesized and released locally.
Frequently viruses spread from local sites of multiplication to macrophages, which may be local (eg, alveolar or subcutaneous) or lining the sinuses of lymph nodes, liver, and spleen. Macrophages provide an important barrier to the spread of virus infections; this barrier is ineffective in very young animals and in certain mature animals with inherited susceptibility to particular virus infections.
The third major defence system is circulating antibody, which frequently limits spread of viruses through the blood stream and their multiplication in target organs such as the brain, liver, or heart. Serum antibody is effective against many viruses, but some-such as herpesviruses, poxviruses and certain myxov-ruses-can spread despite the presence of antibody; cell-mediated immunity plays an important protective role in these cases. It is of interest that several slow virus diseases fall into this category. Whether interferon plays a significant role in defence under conditions of natural intection is still unknown although it can limit virus multiplication under certain rather special conditions. High temperatures can protect susceptible hosts from some virus infections. Interactions of these factors have recently been reviewed (Allison, 1972a) . In this paper comments will be restricted to circulating antibodies and cell-mediated immunity, defects of which are probably most relevant to slow virus infections. (Nathanson and Cole, 1970 (Table III) .
CELL-MEDIATED IMMUNITY
Evidence that viruses can elicit cell-mediated immune responses has been summarized elsewhere (Allison, 1972b (Glasgow, 1970) . A cell-mediated immune reaction against a viral or heterologous antigen is associated with macrophage 'activation'-an increase in the content of lysosomal enzymes and capacity to kill intracellular parasites, including viruses. Finally, cells in which viruses are growing 123 bear viral antigens on their surfaces, and these can be recognized by sensitized lymphocytes which attack and destroy the cells, thereby interrupting the cycle of virus multiplication. This is discussed further in the section on immunopathology. However, lymphocyte transformation may also work against the host: many viruses cannot grow in small lymphocytes unless they are transformed by phytohaemagglutinin or an immune reaction (Bloom, Jimenez, and Marcus, 1970) .
If cell-mediated immunity plays a protective role in virus infections of experimental animals, thymectomy and/or treatment with antilymphocytic serum (ALS) should aggravate the disease. Human patients with hypogammaglobulinaemia but intact cell-mediated immunity should not suffer from severe infections with these viruses, whereas in patients with defective cell-mediated immunity infections should be severe and often progressive.
Experiments on increasing severity of virus infections by thymectomy and ALS are summarized in Table III . It will be seen that the infections aggravated by these procedures are due to herpesvirus and poxviruses, whereas arbovirus and enterovirus infections are not increased in severity. This is consistent with the view that circulating antibody can limit enterovirus and arbovirus infections, whereas cell-mediated immunity is required for resolution of poxvirus and herpesvirus infections. Fulginiti, Kempe, Hathaway, Pearlman, Sieber, Eller, Joyner, and Robinson (1968) described progressive vaccinia in patients with many of these syndromes, particularly Nezelof's syndrome in which immunoglobulin levels and specific antibody-synthesizing capacity are near normal. Patients with the Wiscott-Aldrich syndrome are particularly susceptible to infections produced by cytomegalovirus, measles, and especially herpes simplex viruses (Cooper, Chase, Lowman, Krivit, and Good, 1968) . Patients with cartilage-hair hypoplasia, which is associated with a defect of cell-mediated immunity but normal antibody levels, have unusually severe varicella infections (Lux, Johnston, August, Say, Penchaszadeh, Rosen, and McKusick, 1969 ).
Hodgkin's disease and some other debilitating diseases, cancer chemotherapy, and immunosuppressive therapy after renal homografting, all of which depress cell-mediated to a greater extent than humoral immunity, increase susceptibility to infections, particularly by cytomegalovirus (Craighead, 1969) , herpes simplex virus (Montgomerie, Becroft, Croxson, Doak, and North, 1969) In vivo evidence that antibody plays a role in the pathogenesis of virus infections is less convincing. Depletion of complement by cobra venom decreased the lethal effects of LCM in adult mice, and injections of antibody into the cerebrospinal fluid of LCM carrier mice produced meningeal inflammation (Oldstone and Dixon, 1970) . However, in mice carrying LCM after adult infection with administration of cyclophosphamide (Cole, Gilden, Monjan, and Nathanson, 1971 ) administration of antibody did not produce disease. When mice infected with Langat virus (an arbovirus) were given antibody, some aggravation of disease was reported (Webb, 1969) . However, the timing of the antibody administration was critical, and it seems likely that antibody usually protects the host rather than increasing the severity of virus infections. (Speel, Osborn, and Walker, 1968 (Porter, Larsen, and Porter, 1969) . In contrast, lactic dehydrogenase virus, in which there is a persistent high viraemia, produces only mild renal disease (Porter and Porter, 1971) (Trepo and Thivolet, 1970; Gocke, Hsu, Morgan, Bombardieri, Lockshin, and Christian, 1971) . In five fatal cases of hepatitis, Australia antigen, immunoglobulin, and complement were found in the intima of arterioles showing changes typical of periarteritis (Nowoslawski, Brzosko, Krawczyn'ski, and Madalen'ski, 1972) . A case of immune complex nephritis has been reported with deposition of Australia antigen, IgG, and complement in the glomeruli (Combes, Stastny, Shorey, Eigenbrodt, Barrera, Hull, and Carter, 1971 ) and at necropsy of four fatal cases of hepatitis Australia antigen, IgG, IgM, and complement were found in glomerular capillaries (Nowoslawski et al, 1972) . From observations on synovial tissues, Alpert et al (1971) suggest that immune complexes with Australia antigen contribute to the urticaria and arthritis sometimes associated with hepatitis.
Hypersensitivity in Virus Infections
Reports of local and systemic reactions in recipients of inactivated measles vaccine when subsequently inoculated with live virus vaccine (Buser, 1967; Scott and Bonanno, 1967) or experiencing natural infection (Nader, Horwitz, and Rousseau, 1968) suggest the importance of hypersensitivity reactions in virus infections. In the vaccinated subjects atypical exanthema and swelling and erythema at the site of infection developed over three to eight days. Evidence that this is an Arthus-type reaction has been presented by Bellanti, Sanga, Klutinis, Brandt, and Artenstein (1969) , who found bound immunoglobulin, measles antigen, and complement components in skin biopsies from the sites of local reaction. Chanock, Parrott, Kapikian, Kim, and Brandt (1968) (Latarjet, Muel, Haig, Clarke, and Alper, 1970) and apparent absence of immunogenicity. No antibody has been demonstrable by neutralization, complement fixation, precipitation, or immunofluorescence (Gibbs, Gajdusek, and Morris, 1965; Chandler, 1959) . There are no mononuclear infiltrates of lesions suggestive of a cell-mediated immune response. Neonatal thymectomy (Gibbons and Hunter, 1967) or thymectomy, lethal irradiation, and reconstitution with foetal liver cells, which markedly depletes thymusderived (T) lymphocytes, had no effect on the incubation period or pathology ofscrapie in mice (McFarlin, Raff, Simpson, and Nehlsen, 1971) . This suggests that cell-mediated immunity neither contributes to the pathogenesis of scrapie nor plays a significant role in the host's defence against the agent.
Equine Infectious Anaemia
This disease is restricted to Equidae and is characterized by persistence of virus, haemolytic anaemia with C3-coated erythrocytes, hypergammaglobulinaemia, deposition of y-globulin and C3 in the renal glomeruli (Banks and Henson, 1969) , and decreased circulating C3 levels. The clinical course is variable; some horses have severe haemolytic disease while others become asymptomatic. Infected horses remain viraemic for life, despite the presence of neutralizing and complement-fixing antibody in the serum (McGuire, Crawford, and Henson, 1971) . By immunofluorescence viral antigen is demonstrable in the cytoplasm of peripheral blood leucocytes, macrophages lining blood or lymph sinuses, and other sites. The virus thus apparently replicates in macrophages. The anaemia may result from attachment of viral antigen-antibody-complement complexes to erythrocytes, with their subsequent removal from the circulation.
Aleutian Mink Disease
Aleutian disease is a chronic virus infection of mink, which has caused serious economic losses to commercial ranchers. 'Mutation' mink homozygous for a pale coat colour (Aleutian) gene are particularly susceptible to the disease but other mink also develop chronic infections. Once the infection is established, virus can be recovered from the serum, organs, and urine for the remainder of the animal's life. The primary lesion is a systemic proliferation of plasma cells, and this is associated with marked hyper-gammaglobulinaemia, sometimes of monoclonal (myeloma-like) nature. Glomerulonephritis, degenerative arterial lesions, and proliferation of intrahepatic bile ducts are commonly seen. Porter et al (1969) have shown that Aleutian disease virus replicates rapidly, and attains high titres, especially in the liver. Viral antigen is confined to the cytoplasm of macrophages in spleen and lymph nodes and Kupffer cells in the liver. Very high levels of antibodies (measured by indirect immunofluorescence against viral antigen) were found. Secondary deposits of viral antigen, antibody, and complement are marked in the renal glomeruli where they exhibit the bumpy appearance characteristic of immune complexes. Bound immunoglobulin and complement have also been found in arteriolar walls.
Lactic Dehydrogenase Virus This is a virus infection of mice which, once established in newborn or adult animals, persists for life. Infectious virus continues to circulate in the plasma. It is combined with antibody and can be neutralized by antiserum against mouse immunoglobulin (Notkins, Mahar, Scheele, and Goffman, 1966) . The virus replicates in macrophages (Evans and Salaman, 1965) . Immune complexes are found in the kidneys (Porter and Porter, 1971 ), but they are much less striking than in lymphocytic choriomeningitis virus. Whether a cell-mediated immune response is mounted against this virus has not been investigated.
Visna-maedi
Dr Palsson describes elsewhere in the present volume this complex of progressive infections of the central nervous system and lungs of sheep. Relevant to the present discussion is the fact that virus infection continues to spread despite the presence of neutralizing antibody in serum. Possibly cellmediated immunity plays a part in controlling this myxovirus-like agent (as in measles) and in Icelandic sheep specific cell-mediated immunity is ineffective. A deliberate search for cell-mediated immunity, using virus-infected cells, and for blocking serum factors would be well worth while. Since virus is readily recovered from mononuclear cells in cerebrospinal fluid, most of which are macrophages, virus may be able to replicate in macrophages. Since this would contribute to the persistent infection despite the presence of antibody, it would be worth investigating systematically. Gerson and Haslam (1971) reported that four boys with SSPE had impaired expression of delayed hypersensitivity to skin test antigens and delayed rejection of skin allografts. In three of the four IgA levels were subnormal. In contrast, Jabbour, Roane, and Sever (1969) found that all eight SSPE patients tested had positive skin responses to Candida; two of three patients tested became sensitized to dinitrochlorobenzene. Skin tests with measles antigen (at best a procedure difficult to interpret) were negative. Saunders, Knowles, Chambers, Caspary, GardnerMedwin, and Walker (1969) An interesting animal model has been described by Wear and Rapp (1971) (Leonard, Schmidt, and Lennette, 1970) .
Thus available evidence suggests that varicellazoster virus can remain latent in the body after chickenpox infection, and can emerge when host resistance wanes. In considering resistance against the virus, it appears that there are two components. Antibody can protect against the initial infection. Immune globulin from zoster patients has been found, in double-blind studies, to prevent varicella in exposed children (Brunell, Ross, Miller, and Kuo, 1969 (Gibbs, Shapiro, Cassidy, and Brunell, 1970 (Smith and Vellios, 1950) and in man (Cangir and Sullivan, 1966; Craighead, 129 1969). Cytomegalovirus infections have been troublesome in renal transplant patients (Montgomerie et al, 1969) 
